FitBit and app aim to keep cancer surgery patients out of the hospital
NCT ID NCT03623464
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a FitBit and a mobile app can help people recover at home after surgery for stomach, liver, colon, or other GI cancers. About 107 patients will either use the devices plus standard care, or standard care alone. The app tracks activity and symptoms, and alerts doctors if something seems wrong, with the goal of preventing hospital readmissions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- FitBit and mobile health application
- What this could lead to
- If it works, this could give doctors a simple way to monitor recovery at home and reduce the chance of patients needing to return to the hospital after surgery.
- What could go wrong
- This is a small, early-stage study with only 107 people, so results may not apply to everyone. The devices rely on patients having and using a smartphone, which could limit usefulness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Weill Cornell Medicine- New York Presbyterian
New York, New York, 10021, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Guided home training boost recovery from gastric cancer surgery?
- Digital nurse companion: could an app ease the burden of chronic illness?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new infusion drug shrink Hard-to-Treat tumors?
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early